Notably, in this dataset, patients were not selected for the presence of EGFR mutations or specific treatment with EGFR-TKIs, and the overall conclusion from this analysis is that FAK mRNA levels are not a prognostic marker in NSCLC. Here, PTK2 is linked to non-small cell lung carcinoma.